SCYX-7158 has been used in trials studying the treatment of Trypanosomiasis, Parasitic Diseases, Protozoan Infections, and Trypanosomiasis, African.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.